Bayer Reportedly Explores Sale Of Dermatology Business

(RTTNews.com) – Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) is exploring the sale of its dermatology business, as the German drugmaker sells peripheral businesses and pursues the takeover of Monsanto Co. (MON), the Bloomberg reported citing people familiar with the matter. According to the company, the German company is working with JPMorgan Chase & Co.… Read More »